Latest News

Dow Jones Newswires: GSK says U.S. FDA approves Boostrix for immunization during pregnancy

0
the close up of the five rows coins ,and the coins jar that fell, with the back ground is a dark blue graph.

GSK PLC
GSK,
-0.64%

said Monday that the U.S. Food and Drug Administration has approved Boostrix for immunization during the third trimester of pregnancy to help prevent pertussis, or whooping cough, in infants under two months old.

The U.K.-based maker of cancer and asthma medications said the vaccine–which is given during pregnancy–passes antibodies to babies before birth. The vaccine is also indicated against tetanus, diphtheria and pertussis in individuals aged 10 years and older, GSK said.

Boostrix is currently approved in more than 80 countries including most EU countries, as well as Canada, Australia and New Zealand, as a vaccine for tetanus, diphtheria and pertussis, the company said.

Write to Anthony O. Goriainoff at anthony.orunagoriainoff@dowjones.com

: A majority of Republicans prefer state-level abortion policies, even though they don’t support Roe v. Wade. Here’s why.

Previous article

Dow Jones Newswires: TotalEnergies proposes wage negotiations this month if fuel-depot blockages end

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News